Member

biotechresearch

Total Threads:0 Total Posts:0 Bits:0

Rankings

  • Format
    BeyRank
  • Burst
    N/A
  • Metal
    N/A

Bio

Country: United States Registration Date: Sep. 03, 2021
Traditionally the generic drug makers submitted Abbreviated New Drug Applications (ANDA), however more have been opting for the 505(b)(2) regulatory pathway. The ANDA offers a quicker and more cost-efficient solution than their brand name counterpart, which was approved under a New Drug Application (NDA). Call : 08133332950 Visit : https://biotechresearchgroup.com/an-overlooked-generic-drug-pathway-505b2/

Tournament History

biotechresearch hasn't participated in any recent tournaments.